Kendle (Nasdaq: KNDL) will conduct a telephone conference call andsimultaneous webcast Feb. 27 at 8:30 a.m. Eastern Time to discuss itsfinancial results for the Fourth Quarter and Year Ended Dec. 31, 2007. Aquestion and answer session will follow.
(Logo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGO )
To access the live webcast, go to www.kendle.com orhttp://www.videonewswire.com/event.asp?id=45531. Instructions for accessingthe webcast are provided at both sites. The webcast will be archived atwww.kendle.com (click on "Investors") shortly after the call for on-demandreplay through 5 p.m. Eastern Time on March 28, 2008. Please note thatwebcast participants will not be able to ask questions.
System requirements for the webcast include Windows Media Player softwareand at least a 28.8 Kbps connection to the Internet. Media Player isdownloadable at no charge fromhttp://www.microsoft.com/windows/windowsmedia/default.aspx.
Conference Call Instructions
To register (RSVP) for the telephone conference call, U.S. and Canadianparticipants should dial (800) 223-7104. Participants outside North Americashould dial (706) 645-6519.
To participate in the telephone conference call, interested parties in theUnited States and Canada should dial (800) 399-0069. Participants outsideNorth America should dial (706) 643-3694. A replay will be available through 5p.m. Eastern Time on March 28 by dialing (706) 645-9291 and enteringconference ID number 32648462
Kendle International Inc. (Nasdaq: KNDL) is among the world's leadingglobal clinical research organizations. We deliver innovative and robustclinical development solutions -- from first-in-human studies through marketlaunch and surveillance -- to help the world's biopharmaceutical companiesmaximize product life cycles and grow market share.
Our global clinical development business is focused on five regions --North America, Europe, Asia/Pacific, Latin America and Africa -- to meetcustomer needs. We have conducted clinical trials and provided regulatory andpharmacovigilance services in more than 80 countries. The company was namedthe "Top CRO to Work With" in the Thomson CenterWatch 2007 Survey of U.S.Investigative Sites.
Additional information and investor kits are available upon request fromKendle, 441 Vine Street, Suite 1200, Cincinnati, OH 45202 or from theCompany's Web site at www.kendle.com.CINCINNATI, Jan. 30 /PRNewswire-FirstCall/ -- CALL DATE: Wednesday, Feb. 27, 2008 TIME: 8:30 a.m. Eastern Time HOST: Dr. Candace Kendle, Chairman and CEO
SOURCE Kendle International Inc.